• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

20years

Revisiting the Fifth Principle of the Imperatives for Quality Cancer Care

May 11, 2015/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Planning, Clinical Guidelines, Quality Cancer Care, Survivorship Care NCCS News /by actualize

This month, as part of the 20 Years Later blog series, we are revisiting the fifth principle of the Imperatives for Quality Cancer Care: Access, Advocacy, and Accountability. This principle states: “People with cancer should be provided a range of benefits by all health care plans that includes primary and secondary prevention, early detection, initial treatment, supportive therapies to manage pain, nausea, fatigue and infections, long-term follow up, psychosocial services, palliative care, hospice care, and bereavement counseling.”

We will consider the components of care and assess the availability in today’s health care plans of the following:

  • Primary and Secondary Prevention
  • Supportive Care (psychosocial)

Primary and Secondary Prevention

Primary and secondary preventative measures are actions and interventions designed to prevent cancer from occurring in the first place, or to identify the disease at the earliest stages, with the goal of reducing the impact of the disease.

20 Years Later

In 2015, we’re revisiting the influential “Imperatives for Quality Cancer Care” publication. Read more posts from our “20 Years Later” series.

Since 1991, NCCS has appeared before the Senate and House Committees on Appropriations for the National Institutes of Health to testify on behalf of specific requests for increased research funding to identify the causes of cancer, as well as issues related to diagnosis, prevention, and continued care for cancer patients and their families. An important step toward increasing access to preventive care is the 2010 Affordable Care Act (ACA), which requires that all plans purchased through the Marketplace and some others cover a variety of free preventive services. These include annual wellness visits, cervical and colorectal cancer screening, diet, obesity, and tobacco use screening, and immunization vaccines—all of which are provided without cost-sharing obligations.

Cancer screening is now a complicated process that includes a range of procedures from imaging, to physical exams, to bloodwork and, most recently, to genetic testing. We have closely monitored the Food and Drug Administration (FDA) efforts to develop a strong regulatory framework for Laboratory Developed Tests (LDTs)—sometimes used to diagnose genetic causes of cancer—to encourage more certainty and predictability. We believe the thoughtful and cautious oversight of these tests can reduce harm to patients. If these tests do not accurately diagnose cancer or properly identify a genetic mutation, a patient could be improperly treated, receiving either unnecessary treatment or no treatment at all.

Additionally, there is much to be determined with regards to defining the risks and benefits of screening. For example, mammography and breast cancer screening remains a highly contested issue, with concerns that women are often overdiagnosed, or overtreated for cancers that will not cause harm. Proponents argue that early detection unequivocally saves lives. The discourse surrounding this and other screening issues will continue to change as new technologies and findings emerge, and will require continuous monitoring by patient advocates to ensure that the consumers of these procedures are receiving the right care at the right time.

While progress is being made in making preventive services accessible, responsibility still falls on the patients. Individuals putting off doctors visits, or opting out of screenings altogether, highlight an issue in public health – individual responsibility and consumer awareness. NCCS and other organizations are dedicated to ensuring patients have access to preventive services, that screening guidelines are evidence-based, and that patients are informed of risks and benefits associated with screening.

Supportive Care (psychosocial)

Cancer patients and physicians are becoming more aware of supportive care and psychosocial needs as an integral part of quality cancer care. This includes the emotional stress of living with a diagnosis of cancer and its treatment, fear of recurrence, anxiety about financial obligations, and the distress imposed on patients and their families of living with the day-to-day physical problems cancer may cause. Assessing the psychosocial concerns and coping mechanisms of patients is of increasing interest to researchers and patient groups who believe this component of care has been long subject to neglect.

Cancer-Survival-Toolbox-Eng-Cover

The supporting documents for the Cancer Survival Toolbox include distress screening resources.

NCCS and other organizations have incorporated screening and psychosocial support tools into patient resources. The support documents for the Cancer Survival Toolbox© include the National Comprehensive Cancer Network (NCCN) Guidelines®, a distress management tool that addresses practical, family, emotional, and physical problems, as well as spiritual and religious concerns. Additionally, the Teamwork publication and Pocket Cancer Care Guide iPhone mobile app include a series of questions designed to help facilitate conversations between patients and care providers.

We know that supportive care, including psychosocial care and late and long-term effects are critical to ensuring positive patient outcomes. Survivors and their families should also receive palliative and hospice care when the time is right, and bereavement counseling if necessary. We believe that all cancer patients should receive a cancer care plan to guide their treatment and help coordinate their care. For this reason, we support the Oncology Care Model (OCM), which would require practices to document a care plan that covers diagnosis, treatment goals, plans of treatment, quality of life considerations, care coordination, and psychosocial concerns.

Tags: 20 Years Later, affordable care act, breast cancer, cancer care, Cancer Survivorship, care planning, clinical guidelines, FDA, Patient Navigation, prevention, screening
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2015/01/20years.gif 500 500 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2015-05-11 17:03:092015-05-11 17:03:09Revisiting the Fifth Principle of the Imperatives for Quality Cancer Care
You might also like
FacebookProfile3 ASCO announces new Cancer Survivorship Booklet – download now!
Gap Thumb for Infographic The Affordable Care Act & Cancer Survivorship (INFOGRAPHIC)
StepUplogo Take Action: The Alliance for Childhood Cancer “2014 Childhood Cancer Action Days”
Dome Thumbnail starburst NCCS Policy Comments: Recommending Cancer Survivorship as a Topic for FDA Patient-Focused Drug Development Meetings
NCCS Starburst 250px Health Care Roundup: Trump Drug Pricing Plan; HHS Cuts ACA Navigator Funding; CAR-T Therapy Coverage Issues; Biosimilar News; and More
Coronavirus feat Coronavirus and Cancer Resources for Survivors
NCCS Starburst 250px Health Care Roundup: Kansas Moves Medicaid Expansion; CDC Study: How Patients Reduce Their Drug Costs; Where EHRs Went Wrong; More
ProtectOurCare 1024px ACA Update Jan 19, 2018 | Funding for CHIP and Community Health Centers Hangs in the Balance as Gov’t Shutdown Looms

Latest News

Coronavirus feat

COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) hosted a conversation on February…
Read more
https://canceradvocacy.org/wp-content/uploads/2020/03/Coronavirus-feat.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 11:49:192021-03-02 16:15:47COVID-19 Vaccines and Cancer: A Conversation with Cancer Expert Otis Brawley, MD
Canceradvocacy org default image

National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster

February 24, 2021
NOTE: This press release was originally published on the National Quality Forum (NQF)…
Read more
https://canceradvocacy.org/wp-content/uploads/2019/10/Canceradvocacy-org-default-image.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-24 21:01:392021-02-24 21:01:39National Quality Forum Names NCCS CEO Shelley Fuld Nasso to 2021 Leadership Consortium Roster
HHS Humphrey bldg 1200

NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

February 19, 2021
The National Coalition for Cancer Survivorship (NCCS) joined with the Cancer Leadership…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-02-19 15:06:392021-02-24 19:29:10NCCS and Other Cancer Groups Urge HHS to Keep Six Protected Classes in Medicare Part D Drug Plans

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Dr. Atul Gawande’s Recent “Overkill” Article Examines Screening,... AtulGawande New Headshot ProfilePhoto The Culmination of 20 Years of Advocacy Guest Post: The Progress of Prevention—The Culmination of 20 Years of Adv...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute